Status:
RECRUITING
The DistaSense VITALS Study
Lead Sponsor:
Life Detection Technologies
Collaborating Sponsors:
Nilo Medical Consulting Group
Conditions:
Detection of Heart Rate and Respiratory Rate
Eligibility:
All Genders
22+ years
Brief Summary
A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standa...
Eligibility Criteria
Inclusion
- Age ≥ 22 years
- Fluent in English
- Willing and cognitively able to provide informed consent
- BMI \< 36
- Expected by the investigator to achieve sufficient sleep duration for a minimum of 4 hours of meaningful data (e.g., absence of significant insomnia)
- Able to complete the scripted portion of the evaluation
Exclusion
- Pregnant
- Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment
- Subjects with electronic implants of any kind (e.g. pacemaker)
- Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder
Key Trial Info
Start Date :
August 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07217327
Start Date
August 13 2025
End Date
November 1 2025
Last Update
November 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clayton Sleep Institute
St Louis, Missouri, United States, 63123
2
CTI Clinical Research Center
Cincinnati, Ohio, United States, 45212